Genomics, Proteomics, & Metabolomics
|2 min read
Optimizing Speed and Accuracy of NGS Solutions for Oncology Research
Advanced sequencing solutions make high-precision NGS more accessible for labs of all sizesSponsored by
|3 min read
Rewiring Biological Time and Aging with Epigenome Editing
The bright, new future of therapeutic epigenome editing is already on our doorstep
|3 min read
Researchers Test New, More Reliable Method to Detect Chagas Disease
The DNA-based method would aid in the detection of Chagas disease, which affects 6 million people worldwide
|3 min read
AlidaBio Launches EpiPlex™ Platform to Advance Epitranscriptomic Research
EpiPlex is first platform to offer multitarget, quantitative analysis of RNA modifications to provide comprehensive detection and characterization of the epitranscriptome
|2 min read
GUARDIAN Study: Genomic Newborn Screening Will Transform the Rare Disease Landscape
The GUARDIAN offers proof of principle that we can implement advanced genomic testing on a large scale
|4 min read
Sanger Sequencing for Specific and Small-Scale DNA Testing
Cost, time, and labor considerations still make the Sanger method a better choice amidst new sequencing technologies
|2 min read
Study Reveals 2 New Genes Associated with Variants Linked to Epilepsy, Offering New Hope for Personalized Therapies
By linking epilepsy to specific genetic mutations, the research offers a new framework for understanding the disorder and developing therapies that address its root causes
|2 min read
Groundbreaking Discoveries in the Fight Against Huntington’s Disease
The new molecular findings are essential for further developing diagnostic tools and imaging techniques to detect and monitor Huntington’s disease
|3 min read
Detecting Disease with Only a Single Molecule
Nanopore-based sensors could transform diagnostics
|3 min read
Sample Prep Automation Will Increase Adoption of Proteomics
The field needs high-throughput methods to provide deeper insights for labs and researchers
|4 min read
The Impact of Emerging Dolutegravir Resistance on Global HIV Treatment and Prevention
Dr. Obiageli Okafor discusses growing resistance to dolutegravir and the need for global access to affordable HIV treatment and preventionSponsored by
|3 min read
